Article Menu
Need Help?
No Article Versions Notes Found
Cite
Ellis, P.M.; Morzycki, W.; Melosky, B.; Butts, C.; Hirsh, V.; Krasnoshtein, F.; Murray, N.; Shepherd, F.A.; Soulieres, D.; Tsao, M.S.; et al. The Role of the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors as Therapy for Advanced, Metastatic, and Recurrent Non-Small-Cell Lung Cancer: A Canadian National Consensus Statement. Curr. Oncol. 2009, 16, 27-48. https://doi.org/10.3747/co.v16i1.393
Ellis PM, Morzycki W, Melosky B, Butts C, Hirsh V, Krasnoshtein F, Murray N, Shepherd FA, Soulieres D, Tsao MS, et al. The Role of the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors as Therapy for Advanced, Metastatic, and Recurrent Non-Small-Cell Lung Cancer: A Canadian National Consensus Statement. Current Oncology. 2009; 16(1):27-48. https://doi.org/10.3747/co.v16i1.393
Chicago/Turabian StyleEllis, Peter M., W. Morzycki, B. Melosky, C. Butts, V. Hirsh, F. Krasnoshtein, N. Murray, F. A. Shepherd, D. Soulieres, M. S. Tsao, and et al. 2009. "The Role of the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors as Therapy for Advanced, Metastatic, and Recurrent Non-Small-Cell Lung Cancer: A Canadian National Consensus Statement" Current Oncology 16, no. 1: 27-48. https://doi.org/10.3747/co.v16i1.393
APA StyleEllis, P. M., Morzycki, W., Melosky, B., Butts, C., Hirsh, V., Krasnoshtein, F., Murray, N., Shepherd, F. A., Soulieres, D., Tsao, M. S., & Goss, G. (2009). The Role of the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors as Therapy for Advanced, Metastatic, and Recurrent Non-Small-Cell Lung Cancer: A Canadian National Consensus Statement. Current Oncology, 16(1), 27-48. https://doi.org/10.3747/co.v16i1.393
